Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.
D001202:Ascitic Fluid / Q000276:immunology*; D002460:Cell Line; D004306:Dose-Response Relationship, Immunologic; D005122:Exudates and Transudates / Q000276:immunology; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008970:Molecular Weight; D010051:Ovarian Neoplasms / Q000276:immunology*; D013696:Temperature; D013997:Time Factors